RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Panion & BF Biotech Stock

Panion & BF Biotech Stocks 2024

Panion & BF Biotech Stocks

85.79 M

Ticker

1760.TW

ISIN

TW0001760007

In 2024, Panion & BF Biotech had 85.79 M outstanding stocks, a 0% change from the 85.79 M stocks in the previous year.

The Panion & BF Biotech Stocks history

YEARNUMBER OF STOCKS (undefined TWD)
2024e85.79
202385.79
202285.83
202179.18
202078.18
201978.23
201877.82
201769.48
201669.48
201568.17
201468.19
201360.6
201256.4
201156.3
201055.8
200950.9
200850.9
200750.9
200650.9
200550.9
200446.5

Panion & BF Biotech shares outstanding

The number of shares was Panion & BF Biotech in 2023 — This indicates how many shares 85.791 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Panion & BF Biotech earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Panion & BF Biotech's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Panion & BF Biotech’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Panion & BF Biotech's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Panion & BF Biotech Aktienanalyse

What does Panion & BF Biotech do?

Panion & BF Biotech Inc. is a Canadian company in the field of biotechnology. The company was founded in 2011 and has its headquarters in Vancouver, British Columbia. Panion & BF Biotech Inc. is listed on the Korean Stock Exchange and has offices in Korea and Hong Kong. The history of Panion & BF Biotech Inc. began when the company was founded by a group of experts in the field of biotechnology to develop innovative solutions that promote animal health and improve agricultural production. In recent years, the company has expanded its activities into various sectors and now offers a wide range of products and services tailored to the needs of animal owners and farmers. The business model of Panion & BF Biotech Inc. is based on the development and marketing of biotechnology products for animal health and agricultural production. The company also conducts research and development of new technologies and products aimed at increasing the efficiency of farmers and animal owners. Panion & BF Biotech Inc. works closely with universities and other research institutions to develop new product ideas. The company has various divisions, including the production of animal medicines, microorganisms, probiotics, and prebiotics, feed additives such as enzyme preparations, and urinary tract infection (UTI) tests. Panion & BF Biotech Inc. is also involved in the development of technologies such as gene editing and CRISPR/Cas9. The company also develops solutions to combat antibiotic resistance in livestock. In recent years, the company has developed and launched a number of products. One of these products is Aivlosin, an animal medicine used to treat respiratory diseases and infections in pigs and chickens. Aivlosin is also approved in North America and Europe. Another product from Panion & BF Biotech Inc. is the probiotic Smaart, which can improve the intestinal health of pigs and chickens. Panion & BF Biotech Inc. works closely with animal owners and farmers to understand their needs and develop products and services that help them overcome their challenges. The company has a broad customer base in various regions of the world, including North America, Europe, and Asia. Overall, Panion & BF Biotech Inc. has become a major player in the biotechnology industry. The company specializes in developing products that promote animal health and improve agricultural production. Panion & BF Biotech Inc. is committed to further investing in research and development of new technologies to meet the needs of animal owners and farmers. Panion & BF Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Panion & BF Biotech's Shares Outstanding

Panion & BF Biotech's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Panion & BF Biotech’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Panion & BF Biotech’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Panion & BF Biotech’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Panion & BF Biotech stock

How many stocks are there of Panion & BF Biotech?

The current number of stocks of Panion & BF Biotech is 85.79 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Panion & BF Biotech are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Panion & BF Biotech evolved in recent years?

The number of shares of Panion & BF Biotech has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Panion & BF Biotech as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Panion & BF Biotech?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Panion & BF Biotech pay?

Over the past 12 months, Panion & BF Biotech paid a dividend of 2 TWD . This corresponds to a dividend yield of about 2.13 %. For the coming 12 months, Panion & BF Biotech is expected to pay a dividend of 2 TWD.

What is the dividend yield of Panion & BF Biotech?

The current dividend yield of Panion & BF Biotech is 2.13 %.

When does Panion & BF Biotech pay dividends?

Panion & BF Biotech pays a quarterly dividend. This is distributed in the months of July, July, August, July.

How secure is the dividend of Panion & BF Biotech?

Panion & BF Biotech paid dividends every year for the past 10 years.

What is the dividend of Panion & BF Biotech?

For the upcoming 12 months, dividends amounting to 2 TWD are expected. This corresponds to a dividend yield of 2.13 %.

In which sector is Panion & BF Biotech located?

Panion & BF Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Panion & BF Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Panion & BF Biotech from 7/10/2024 amounting to 1.5 TWD, you needed to have the stock in your portfolio before the ex-date on 6/13/2024.

When did Panion & BF Biotech pay the last dividend?

The last dividend was paid out on 7/10/2024.

What was the dividend of Panion & BF Biotech in the year 2023?

In the year 2023, Panion & BF Biotech distributed 1.5 TWD as dividends.

In which currency does Panion & BF Biotech pay out the dividend?

The dividends of Panion & BF Biotech are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Panion & BF Biotech

Our stock analysis for Panion & BF Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Panion & BF Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.